Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease:A NTM-NET study

Autor: Henriette Zweijpfenning, Sanne Maria, Chiron, Raphael, Essink, Sharon, Schildkraut, Jodie, Akkerman, Onno W., Aliberti, Stefano, Altenburg, Josje, Arets, Bert, van Braeckel, Eva, Delaere, B. nédicte, Gohy, Sophie, Haarman, Eric, Lorent, Natalie, McKew, Genevieve, Morgan, Lucy, Wagner, Dirk, van Ingen, Jakko, Hoefsloot, Wouter
Přispěvatelé: Microbes in Health and Disease (MHD), Pulmonary medicine, Pediatrics, Amsterdam Reproduction & Development (AR&D), UCL - (SLuc) Centre de référence pour la mucoviscidose, UCL - (SLuc) Service de pneumologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, Pulmonology, AII - Infectious diseases
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Henriette Zweijpfenning, S M, Chiron, R, Essink, S, Schildkraut, J, Akkerman, O W, Aliberti, S, Altenburg, J, Arets, B, van Braeckel, E, Delaere, B N, Gohy, S, Haarman, E, Lorent, N, McKew, G, Morgan, L, Wagner, D, van Ingen, J & Hoefsloot, W 2022, ' Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease : A NTM-NET study ', Chest, vol. 162, no. 1, pp. 76-81 . https://doi.org/10.1016/j.chest.2022.01.015
Chest, 162(1), 76-81. ELSEVIER SCIENCE BV
Chest, 162, 76-81
Chest, 162(1), 76-81. American College of Chest Physicians
Chest, Vol. 19, no. (22), p. 00051-4 (2022)
Chest, 162, 1, pp. 76-81
ISSN: 0012-3692
DOI: 10.1016/j.chest.2022.01.015
Popis: ispartof: CHEST vol:162 issue:1 pages:76-81 ispartof: location:United States status: published
Databáze: OpenAIRE